Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 1/20 | 0.79 |
| ▸ | SLC6A19 | Q695T7 | 1/20 | 0.61 |
| ▸ | BACE1 | P56817 | 1/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.59 |
| ▸ | PLAAT5 | Q96KN8 | 1/20 | 0.58 |
| ▸ | PLAAT4 | Q9UL19 | 1/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 3/20 | 0.56 |
| ▸ | MAOA | P21397 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | RELA | Q04206 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1035544 | 1.00 | HSD17B3 (0.79) | HSD17B3SLC6A19BACE1CYP2D6CYP1B1 | |
| SCHEMBL29162914 | 0.91 | HSD17B3 (0.71) | HSD17B3SLC6A19BACE1CYP2D6CYP1B1 | |
| SCHEMBL17157823 | 0.89 | HSD17B3 (0.69) | HSD17B3SLC6A19BACE1CYP2D6CYP1B1 | |
| SCHEMBL17157819 | 0.89 | HSD17B3 (0.69) | HSD17B3SLC6A19BACE1CYP2D6CYP1B1 | |
| Potassium Ion SCHEMBL17157820 | 0.89 | HSD17B3 (0.69) | HSD17B3SLC6A19BACE1CYP2D6CYP1B1 | |
| SCHEMBL11586083 | 0.86 | HSD17B3 (0.76) | HSD17B3SLC6A19BACE1CYP2D6CYP1B1 | |
| SCHEMBL11586088 | 0.86 | HSD17B3 (0.76) | HSD17B3SLC6A19BACE1CYP2D6CYP1B1 | |
| SCHEMBL236623 | 0.86 | HSD17B3 (0.76) | HSD17B3SLC6A19BACE1CYP2D6CYP1B1 | |
| SCHEMBL236624 | 0.86 | HSD17B3 (0.76) | HSD17B3SLC6A19BACE1CYP2D6CYP1B1 | |
| SCHEMBL31320929 | 0.86 | HSD17B3 (0.76) | HSD17B3SLC6A19BACE1CYP2D6CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8168307-B2 | Organic compound, charge transport material and organic electroluminescent device | PIONEER CORPORATION (JP) | 2012-05-01 | — | — | US | disclosed |
| US-8168307-B2 | Organic compound, charge transport material and organic electroluminescent device | PIONEER CORPORATION (JP) | 2012-05-01 | — | — | US | disclosed |
| EP-2275409-A1 | Bipiridine derivative and organic electroluminescence element containing the same | Yamagata Promotional Organization for Industrial Technology (JP) | 2011-01-19 | — | — | EP | disclosed |
| EP-2275409-A1 | Bipiridine derivative and organic electroluminescence element containing the same | Yamagata Promotional Organization for Industrial Technology (JP) | 2011-01-19 | — | — | EP | disclosed |
| US-20100327265-A1 | BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME | YAMAGATA PROMOTIONAL ORGANIZATION FOR INDUSTRIAL TECHNOLOGY (JP) | 2010-12-30 | — | — | US | disclosed |
| US-20100327265-A1 | BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME | YAMAGATA PROMOTIONAL ORGANIZATION FOR INDUSTRIAL TECHNOLOGY (JP) | 2010-12-30 | — | — | US | disclosed |
| US-20100327265-A1 | BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME | YAMAGATA PROMOTIONAL ORGANIZATION FOR INDUSTRIAL TECHNOLOGY (JP) | 2010-12-30 | — | — | US | disclosed |
| US-20090021146-A1 | ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | PIONEER CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
| US-20090021146-A1 | ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | PIONEER CORPORATION (JP) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090021146-A1 | ORGANIC COMPOUND, CHARGE TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | SLC25A21, SLCO2A1, OCIAD2 | HSD17B3 2485/4885SLC6A19 392/4885BACE1 3515/4885 |
| US-20100327265-A1 | BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME | NFE2L2, SLC19A2, AOC2 | HSD17B3 2739/4885SLC6A19 56/4885BACE1 4174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.